IRIS UniCatt

Paris, Ida
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.682
AS - Asia 1.443
EU - Europa 1.093
SA - Sud America 361
AF - Africa 51
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 3
Totale 4.639
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.620
SG - Singapore 728
CN - Cina 309
BR - Brasile 298
SE - Svezia 252
IT - Italia 216
DE - Germania 177
IN - India 101
FR - Francia 94
VN - Vietnam 92
GB - Regno Unito 74
IE - Irlanda 64
FI - Finlandia 61
ID - Indonesia 49
RU - Federazione Russa 30
HK - Hong Kong 29
AR - Argentina 28
CA - Canada 27
MX - Messico 22
PH - Filippine 21
ES - Italia 19
PL - Polonia 19
KR - Corea 18
TR - Turchia 18
ZA - Sudafrica 18
AT - Austria 15
BD - Bangladesh 15
BE - Belgio 15
CI - Costa d'Avorio 13
UA - Ucraina 13
JP - Giappone 12
NL - Olanda 11
CO - Colombia 10
IR - Iran 9
PK - Pakistan 9
EC - Ecuador 8
VE - Venezuela 8
IQ - Iraq 7
KE - Kenya 5
KZ - Kazakistan 5
MA - Marocco 5
RO - Romania 5
BZ - Belize 4
CZ - Repubblica Ceca 4
EU - Europa 4
JO - Giordania 4
BG - Bulgaria 3
CH - Svizzera 3
CL - Cile 3
CR - Costa Rica 3
HU - Ungheria 3
PE - Perù 3
SA - Arabia Saudita 3
TN - Tunisia 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AU - Australia 2
ET - Etiopia 2
IL - Israele 2
JM - Giamaica 2
LT - Lituania 2
MY - Malesia 2
NO - Norvegia 2
RS - Serbia 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
CG - Congo 1
CY - Cipro 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
HN - Honduras 1
HR - Croazia 1
IM - Isola di Man 1
IS - Islanda 1
KG - Kirghizistan 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PA - Panama 1
PT - Portogallo 1
PY - Paraguay 1
SC - Seychelles 1
SV - El Salvador 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
Totale 4.639
Salva come PNG Salva come JPEG
Città #
Singapore 403
Chandler 278
Ashburn 186
New York 79
Hyderabad 65
Dublin 62
Beijing 61
Los Angeles 58
Munich 57
Rome 50
Chicago 47
Hefei 46
Jakarta 41
The Dalles 38
São Paulo 36
San Mateo 32
Milan 31
Ann Arbor 29
Boston 29
Frankfurt am Main 29
Ho Chi Minh City 28
Wilmington 28
Hong Kong 27
Bremen 26
Princeton 26
Fairfield 24
Turku 23
Helsinki 21
Hanoi 20
Buffalo 19
London 18
Marseille 18
Nuremberg 17
Seoul 17
Boardman 16
Jacksonville 16
Salt Lake City 15
Brussels 14
Kent 14
Lappeenranta 14
Moscow 14
Nanjing 14
Warsaw 14
Abidjan 13
Seattle 12
Rio de Janeiro 11
Tokyo 11
Dallas 10
Izmir 10
Lancaster 10
Lauterbourg 10
Phoenix 10
Santa Clara 10
Tampa 10
Brooklyn 9
Cattolica 9
Düsseldorf 9
Houston 9
Johannesburg 9
Augusta 8
Florence 8
Haiphong 8
North Bergen 8
Porto Alegre 8
Stockholm 8
Vienna 8
Council Bluffs 7
Elk Grove Village 7
San Francisco 7
Toronto 7
Andover 6
Belo Horizonte 6
Dearborn 6
Denver 6
Kunming 6
Manchester 6
Orem 6
Paris 6
Portsmouth 6
San Diego 6
Tianjin 6
Woodbridge 6
Bexley 5
Bogotá 5
Buenos Aires 5
Chennai 5
Guangzhou 5
Guayaquil 5
Mexico City 5
Montreal 5
Nanchang 5
Pasig 5
Quezon City 5
Redwood City 5
Shenyang 5
Shenzhen 5
Sterling 5
Amman 4
Amsterdam 4
Atlanta 4
Totale 2.505
Salva come PNG Salva come JPEG
Nome #
Neoadjuvant chemotherapy in breast cancer: An advanced personalized multidisciplinary prehabilitation model (apmp-m) to optimize outcomes 281
BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study 174
Development of a digital research assistant for the management of patients’ enrollment in oncology clinical trials within a research hospital 172
Multiple Bayesian network meta-analyses to establish therapeutic algorithms for metastatic triple negative breast cancer 137
Level II Oncoplastic Surgery as an Alternative Option to Mastectomy with Immediate Breast Reconstruction in the Neoadjuvant Setting: A Multidisciplinary Single Center Experience 136
Secondary cytoreduction plus oxaliplatin-based HIPEC in platinum-sensitive recurrent ovarian cancer patients: a pilot study 131
Impact of bevacizumab containing first line chemotherapy on recurrent disease in epithelial ovarian cancer: A case-control study 127
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence 122
BRCA Mutation Status in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Pivotal Role for Treatment Decision-Making 121
Techniques for sentinel node biopsy in breast cancer 121
Prospective Study Investigating the Efficacy and Safety of a Scalp Cooling Device for the Prevention of Alopecia in Women Undergoing (Neo)Adjuvant Chemotherapy for Breast Cancer 118
Pregnancy-Associated Breast Cancer: A Multidisciplinary Approach 117
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial 115
Development of a digital research assistant for the management of patients’ enrollment in oncology clinical trials within a research hospital 114
Palbociclib plus fulvestrant or everolimus plus exemestane for pretreated advanced breast cancer with lobular histotype in er+/her2− patients: A propensity score-matched analysis of a multicenter retrospective patient series 108
Breast cancer drug approvals issued by EMA: A review of clinical trials 107
Ovarian reserve after chemotherapy in breast cancer: A systematic review and meta-analysis 105
Identification of twenty-nine novel germline unclassified variants of BRCA1 and BRCA2 genes in 1400 Italian individuals 100
Real-world management of trabectedin/pegylated liposomal doxorubicin in platinum-sensitive recurrent ovarian cancer patients: A national survey 100
Multigenic panels in breast cancer: Clinical utility and management of patients with pathogenic variants other than BRCA1/2 98
Cdk4/6 inhibitor treatments in patients with hormone receptor positive, her2 negative advanced breast cancer: Potential molecular mechanisms, clinical implications and future perspectives 98
Accessible model predicts response in hormone receptor positive HER2 negative breast cancer receiving neoadjuvant chemotherapy 97
Anthracyclines strike back: Rediscovering non‐pegylated liposomal doxorubicin in current therapeutic scenarios of breast cancer 95
Oligometastatic Breast Cancer: How to Manage It? 94
Characterization of a new BRCA1 rearrangement in an Italian woman with hereditary breast and ovarian cancer syndrome 91
Palliative electrochemotherapy in primary or recurrent vulvar cancer 91
Pregnancy-Associated Breast Cancer: A Multidisciplinary Approach 90
Upfront HIPEC and bevacizumab-containing adjuvant chemotherapy in advanced epithelial ovarian cancer 89
Conservative Surgery in cT4 Breast Cancer: Single-Center Experience in the Neoadjuvant Setting 85
Development of a nomogram for predicting pathological complete response in luminal breast cancer patients following neoadjuvant chemotherapy 84
Role of radiomics in predicting early disease recurrence in locally advanced breast cancer patients: integration of radiomic features and RECIST criteria 83
Neoadjuvant Chemotherapy Followed by Maintenance Therapy With or Without Bevacizumab in Unresectable High-Grade Serous Ovarian Cancer: A Case-Control Study 83
Impact of scalp cooling device (SCD) in preventing alopecia in women undergoing chemotherapy for breast cancer 83
An Innovative Scoring System to Select the Optimal Surgery in Breast Cancer after Neoadjuvant Chemotherapy 82
Germline BRCA 1-2 status prediction through ovarian ultrasound images radiogenomics: a hypothesis generating study (PROBE study) 81
Baseline 18F-FDG PET/CT for predicting pathological response to neoadjuvant chemotherapy and prognosis in locally advanced breast cancer patients: analysis of tumor and lymphoid organs metabolic parameters 80
Overall survival of CDK4/6-inhibitors-based treatments in clinically relevant subgroups of metastatic breast cancer: systematic review and meta-analysis 80
Updated Neoadjuvant Treatment Landscape for Early Triple Negative Breast Cancer: Immunotherapy, Potential Predictive Biomarkers, and Novel Agents 79
Spectrum of germline BRCA1 and BRCA2 variants identified in 2351 ovarian and breast cancer patients referring to a reference cancer hospital of Rome 78
Neoadjuvant Chemotherapy in Breast Cancer: An Advanced Personalized Multidisciplinary Prehabilitation Model (APMP-M) to Optimize Outcomes 78
Level II Oncoplastic Surgery as an Alternative Option to Mastectomy with Immediate Breast Reconstruction in the Neoadjuvant Setting: A Multidisciplinary Single Center Experience 71
PI3K Inhibitors in Advanced Breast Cancer: The Past, The Present, New Challenges and Future Perspectives 65
Malignant Mesenchymal Tumors of the Breast: Current Challenges and New Perspectives on Primary Sarcomas and Malignant Phyllodes Tumors 65
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting 56
Clinical impact of drug-drug interactions on abemaciclib in the real-world experience of AB-ITALY study 48
Assessing the pathogenicity of BRCA1/2 variants of unknown significance: Relevance and challenges for breast cancer precision medicine 44
Neoadjuvant therapy for triple-negative breast cancer: potential predictive biomarkers of activity and efficacy of platinum chemotherapy, PARP- and immune-checkpoint-inhibitors 33
Lifestyle and environmental factors in women carrying BRCA pathogenic variants with and without cancer 2
Totale 4.709
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.198
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.198
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202152 0 0 0 0 0 2 8 2 8 8 17 7
2021/2022368 24 17 10 27 11 28 15 51 18 21 78 68
2022/2023761 93 102 66 126 29 100 46 57 94 14 17 17
2023/2024463 15 92 19 29 22 75 52 24 12 22 44 57
2024/20251.325 22 19 105 39 94 52 40 49 130 196 377 202
2025/20261.555 371 98 187 367 497 35 0 0 0 0 0 0
Totale 4.709